KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Change in Cash (2016 - 2025)

Zimmer Biomet Holdings has reported Change in Cash over the past 17 years, most recently at -$700.8 million for Q4 2025.

  • Quarterly results put Change in Cash at -$700.8 million for Q4 2025, down 1507.34% from a year ago — trailing twelve months through Dec 2025 was $66.4 million (down 39.47% YoY), and the annual figure for FY2025 was $66.4 million, down 39.47%.
  • Change in Cash for Q4 2025 was -$700.8 million at Zimmer Biomet Holdings, down from $735.8 million in the prior quarter.
  • Over the last five years, Change in Cash for ZBH hit a ceiling of $859.1 million in Q1 2025 and a floor of -$827.7 million in Q2 2025.
  • Median Change in Cash over the past 5 years was -$35.2 million (2022), compared with a mean of -$10.5 million.
  • Peak annual rise in Change in Cash hit 3884.58% in 2025, while the deepest fall reached 3154.24% in 2025.
  • Zimmer Biomet Holdings' Change in Cash stood at -$441.1 million in 2021, then skyrocketed by 61.53% to -$169.7 million in 2022, then skyrocketed by 172.83% to $123.6 million in 2023, then plummeted by 135.28% to -$43.6 million in 2024, then crashed by 1507.34% to -$700.8 million in 2025.
  • The last three reported values for Change in Cash were -$700.8 million (Q4 2025), $735.8 million (Q3 2025), and -$827.7 million (Q2 2025) per Business Quant data.